Adam Thomas is an experienced QC Senior Scientist specializing in Analytical Method Validation at Genezen since August 2025. Prior to this role, Adam held several positions at Dragonfly Therapeutics, Inc., from January 2021 to June 2025, including Associate Director of Quality Control and Principal Scientist & Senior QC Manager. Adam's earlier experience includes a Scientist/Manager role at Homology Medicines, Inc., where responsibilities involved testing gene therapy products, and positions at MassBiologics, where Adam managed the Quality Control Bioassay group. Adam began a research career as a Postdoctoral Fellow at the National Cancer Institute, focusing on molecular biology, and holds a Ph.D. in Genetics and Molecular Biology from Tufts University. Adam's educational background also includes a Bachelor's degree in Biology from Boston University.
This person is not in any teams
This person is not in any offices